dddd
PublishedFebruary 28, 2013

Patents in the News 2/28

FTC-Google public comments round-up #2: Tech companies have their say
The Essential Patent Blog
February 28, 2013
Yesterday we covered several public comments submitted to the FTC by various professional organizations and trade/industry associations surround the FTC-Google consent decree.  Today, we’re here to tackle the submissions from several large companies that chose to comment on the FTC order.  These companies include Apple, Ericsson, Microsoft, Qualcomm, and Research in Motion.

Troll hunter: meet the Oregon lawmaker who may fix the patent mess
Rep. Peter DeFazio took on the issue after a local software company got held up.
Ars Technica (US)
February 28, 2013
Joe Mullin
This morning, Representatives Peter DeFazio (D-OR) and Jason Chaffetz (R-UT) introduced the SHIELD Act, which would create a “loser pays” system for some types of patent litigants. The bill is meant to stymie companies that do nothing more than file patent lawsuits.

Peeved politicians want “loser pays” rule for patent trolls
SHIELD Act would target patent shell companies, exempt inventors, universities.
Ars Technica (US)
February 27, 2013
Joe Mullin
Last year, the first bill that could take a bite out of the business model of so-called “patent trolls” was introduced. Not much happened with it, but today a reworked bill has been introduced by the same sponsors: Reps. Jason Chaffetz (R-UT) and Peter DeFazio (D-OR). The bill is called the SHIELD Act of 2013, which stands for “Saving High-Tech Innovators from Egregious Legal Disputes.”

 

circle 09

Josh Lamel

More Posts

Another startup bites the dust, courtesy of patent trolls

A handful of interest groups like to claim that patent trolls are a myth—that they're a straw man used to shape IP policy in ways that are harmful to patent holders. Mycroft AI is one of many startu...

How Challenging Low Quality Patents is Lowering Drug Prices

The FTC made headlines in May when it announced it was challenging over 300 “junk” patents in the FDA’s “Orange Book,” including patents on popular drugs like Ozempic and Victoza. With this ...

Incremental Progress on Valve

In March, U.S. Patent and Trademark Office Director Kathi Vidal vacated earlier Patent Trial and Appeal Board (PTAB) decisions that denied patent validity challenges brought by Honda Motor Co., Genera...

Subscribe to Patent Progress

No spam. Unsubscribe anytime.